Volume 10; Issue 2 Suppleme

Breast Cancer Research

Volume 10; Issue 2 Suppleme
1

Molecular diversity of human breast cancer: clinical and therapeutic implications

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
2

Surviving breast cancer: can women expect to 'get back to normal'?

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
3

Identification of components of the ubiquitin system as targets for therapeutic intervention

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
4

Abnormal expression of p53 isoforms can be associated with poor survival in primary breast tumours

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
5

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
6

Chromosomal instability in the pathogenesis and treatment of breast cancer

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
11

Health inequalities in breast cancer screening

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
15

Regulation of cyclin D1by the BRCA1–BARD1 complex

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
19

Activation of TGF-beta signalling in breast cancer metastatic cells

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
32

Chromosome translocations in breast cancer

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
38

Bevacizumab resistance in breast cancer: are neuropilins the key?

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
43

Proapoptotic protein Bid is regulated by phosphorylation during anoikis and the cell cycle

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
48

Cellular localization of the proto-oncogenic p53 inhibitor AGR2 protein in breast cancer

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
52

Adherence to hormone therapy in a chemoprevention randomised trial

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
54

Living with genetic risk of breast cancer: what have we learned?

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
55

MCPH1, a potential predictor for response to cancer chemotherapy

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
56

Homeopathy service in an NHS hospital breast cancer clinic: outcome study

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
76

Role of CLEVER-1 in breast cancer metastasis

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
78

Interactions between BRCA2 protein and the meiosis-specific recombinase DMC1

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
91

Breast cancer and environmental risk factors: an appraisal of the scientific evidence

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
93

Inhibitor of apoptosis proteins as a therapeutic target in breast cancer

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
94

Discrepancies and challenge of ductal carcinomain situfor health professionals

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
98

Investigating h-Prune activation of Wnt signalling in breast cancer

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
101

Regulation of estrogen receptor beta by 5' untranslated regions in breast carcinogenesis

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
102

Expression analysis of novel biomarkers for breast cancer

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008
104

Use of BRCA1 protein:protein interactions to classify cancer risk

Year:
2008
Language:
english
File:
PDF, 2.44 MB
english, 2008